Homelessness, Mental Illness, Substance Abuse, and HIV: An Insidious Syndemic
DOI:
https://doi.org/10.17140/HARTOJ-1-e001Abstract
Mahatma Gandhi once said that the measure of a country’s greatness is in how it treats its least fortunate members. In his last public speech, Hubert Humphrey echoed the same sentiment when he said “…the moral test of government is how that government treats those who are in the dawn of life, the children; those who are in the twilight of life, the elderly; those who are in the shadows of life; the sick, the needy and the handicapped” (Remarks at the dedication of the Hubert H. Humphrey Building, November 1, 1977, Congressional Record, November 4, 1977, vol 123, p. 37287).
References
Chambers C, Chiu S, Scott AN, et al. Factors associated with poor mental health status among homeless women with and without dependent children. Community Mental Health Journal. 2013; (in press). doi: 10.1007/s10597-013-9605-7
Caton CLM, El-Bassel N, Gelman A, Barrow S, et al. Rates and Correlates of HIV and STI Infection Among Home-less Women. AIDS and Behavior. 2013; 17(3): 856-864. doi: 10.1007/s10461-012-0198-x
Culhane DP, Metraux S, Byrne T, Stino M, et al. The age structure of contemporary homelessness: evidence and impli-cations for public policy. Analyses of Social Issues and Public Policy. 2013; 13(1): 228-244. doi: 10.1111/asap.12004
Denning P, DiNenno E. Communities in Crisis: Is There a Generalized HIV Epidemic in Impoverished Urban Areas of the United States? International AIDS Conference. 2010; 21.
Gambatese M, Marder D, Begier E, Gutkovich A, et al. Programmatic Impact of 5 Years of Mortality Surveillance of New York City Homeless Populations. American Journal of Public Health. 2013; 103 Suppl 2: S193-S198. doi: 10.2105/ AJPH.2012.301196
Aidala AA, Sumartojo E. Why housing? AIDS and Behavior. 2007; 11(6 Suppl): 1-6. doi: 10.1007/s10461-007-9302-z
Bacon J, Lavis JN, Rourke S. Addressing Housing Chal-lenges Faced by People with HIV in Ontario. McMaster Health Forum. 2010; 16.
Rothbard AB, Blank MB, Staab JP, TenHave T, et al. Pre-viously Undetected Metabolic Syndromes and Infectious Dis-eases Among Psychiatric Inpatients. Psychiatric Services. 2009; 60(4): 534-537. doi: 10.1176/appi.ps.60.4.534
DiClemente RJ, Wingood GM, Blank MB, Metzger DS. Fu-ture directions for HIV prevention research - Charting a preven-tion science research agenda. JAIDS-Journal of Acquired Im-mune Deficiency Syndromes. 2008; 47 Suppl 1: S47-S48. doi:
1097/QAI.0b013e3181605e5d 10. Walkup J, Blank MB, Gonzalez JS, Safren S, et al. The im-pact of mental health and substance abuse factors on HIV pre-vention and treatment. JAIDS-Journal of Acquired Immune De-ficiency Syndromes. 2008; 47 Suppl 1: S15-S19. doi: 10.1097/ QAI.0b013e3181605b26
Singer M. Introduction to syndemics: A critical systems ap-proach to public and community health. San Francisco, CA: Wiley; 2009.
Milstein B, Homer J, Hirsch G. Analyzing national health reform strategies with a dynamic simulation model. American Journal of Public Health. 2010; 100(5): 811-819. doi: 10.2105/ AJPH.2009.174490
Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occur-rence of HIV and serious mental illness among Medicaid recipi-ents. Psychiatric Services. 2002; 53(7): 868-873. doi: 10.1176/ appi.ps.53.7.868
Susser E, Valencia E, Conover S. Prevalence of HIV-infec-tion among psychiatric patients in a New York City men’s Shel-ter. American Journal of Public Health. 1993; 83(4): 568-570. doi: 10.2105/AJPH.83.4.568
Rosenberg SD, Goodman LA, Osher FC, Swartz MS, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health. 2001; 91(1): 31-37.
Himelhoch S, McCarthy JF, Ganoczy D, Medoff D, et al. Understanding associations between serious mental illness and HIV among patients in the VA health system. Psychiatric Ser-vices. 2007; 58(9): 1165-1172.
Blank MB, Himelhoch SS, Balaji AB, Metzger DS, et al. A Multisite Study of the Prevalence of HIV using Rapid Testing in Mental Health Settings. American Journal of Public Health. 2014; (in press). doi: 10.2105/AJPH.2013.301633
Gill VS, Lima VD, Zhang W, Wynhoven B, et al. Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detec-tion. Clinical Infectious Diseases. 2010; 50(1): 98-105. doi: 10.1086/648729
Das M, Chu PL, Santos GM, Scheer S, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010; 5: e11068. doi: 10.1371/journal.pone.0011068
Conviser R, Pounds M. The role of ancillary services in cli-ent-centred systems of care. AIDS Care. 2002; 14 Suppl: S119- S131. doi: 10.1080/09540120220150018
Perkins D, Meyerson B, Klinkenberg D, Laffoon B. As-sessing HIV care and unmet need: Eight data bases and a bit of perseverance. AIDS Care. 2008; 20(3): 318-326. doi: 10.1080/09540120701594784
Ikard K, Janney J, Hsu LC, Isenberg DJ, et al. Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Education & Prevention. 2005; 17(6 Suppl B): 26-38. doi: 10.1521/aeap.2005.17.Supplement
Olatosi BA, Probst JC, Stoskopf CH, Martin AB, Duffus WA. Patterns of engagement in care by HIV-infected adults: South Carolina, 2004-2006. AIDS. 2009; 23(6): 725. doi: 10.1097/ QAD.0b013e328326f546
Hill T, Bansi L, Sabin C, Phillips A, et al. Data linkage re-duces loss to follow-up in an observational HIV cohort study. Journal of Clinical Epidemiology. 2010; 63(10): 1101-1109. doi: 10.1016/j.jclinepi.2009.12.007
Arici C, Ripamonti D, Maggiolo F, Rizzi M, et al. Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clinical Trials. 2002; 3(1): 52-57. doi: 10.1310/2XAK-VBT8-9NU9-6VAK
Coleman S, Boehmer U, Kanaya F, Grasso C, et al. Retention challenges for a community-based HIV primary care clinic and implications for intervention. AIDS Patient Care and STDs. 2007; 21(9): 691-701. doi: 10.1089/apc.2006.0205
Mocroft A, Kirk O, Aldins P, Chies A, et al. Loss to fol-low-up in an international, multicentre observational study. HIV Medicine. 2008; 9(5): 261-269. doi: 10.1111/j.1468-1293- .2008.00557.x
Parienti JJ, Massari V, Descamps D, Vabret A, et al. Pre-dictors of virologic failure and resistance in HIV-infected pa-tients treated with nevirapine-or efavirenz-based antiretroviral therapy. Clinical Infectious Diseases. 2004; 38(9): 1311-1316. doi: 10.1086/383572
Sterne JA, May M, Costagliola D, de Wolf F, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infect-ed patients: a collaborative analysis of 18 HIV cohort studies. The Lancet. 2009; 373(9672): 1352-1363. doi: 10.1016/S0140- 6736(09)60612-7
Arnsten JH, Demas PA, Grant RW, Gourevitch MN, et al. Impact of Active Drug Use on Antiretroviral Therapy Adher-ence and Viral Suppression in HIV-infected Drug Users. Journal of General Internal Medicine. 2002; 17(5): 377-381.
Rothbard AB, Metraux S, Blank MB. Cost of care for med-icaid recipients with serious mental illness and HIV infection or AIDS. Psychiatric Services. 2003; 54(9): 1240-1246.
Blank MB, Eisenberg MM. Tailored treatment for HIV+ persons with mental illness: the intervention cascade. JAIDS-Journal of Acquired Immune Deficiency Syndromes. 2013; 63 Suppl 1: S44-S48.doi: 10.1097/QAI.0b013e318293067b
Blank MB, Hennessy M, Eisenberg MM. Increasing Quality of Life and Reducing HIV Burden: The PATH+ Intervention. AIDS and Behavior. 2013; (in press).doi: 10.1007/s10461-013- -0606-x
Blank MB, Hanrahan NP, Fishbein M, Wu ES, et al. A Randomized Trial of a Nursing Intervention for HIV Disease Management among Persons With Serious Mental Illness. Psy-chiatric Services. 2011; 62(11): 1318-1324. doi: 10.1176/appi. ps.62.11.1318
Blank MB, Himelhoch S, Walkup J, Eisenberg MM. Treat-ment Considerations for HIV-Infected Individuals with Severe Mental Illness. Current HIV/AIDS Reports. 2013; 10(4): 371- 379. doi: 10.1007/s11904-013-0179-3
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in HIV/AIDS Research and Treatment (HRT) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.